ZA822344B - Derivatives of 2-piperazino pyrimidine, methods for their preparation and their utilization as drugs or intermediates for the manufacture of drugs - Google Patents

Derivatives of 2-piperazino pyrimidine, methods for their preparation and their utilization as drugs or intermediates for the manufacture of drugs

Info

Publication number
ZA822344B
ZA822344B ZA822344A ZA822344A ZA822344B ZA 822344 B ZA822344 B ZA 822344B ZA 822344 A ZA822344 A ZA 822344A ZA 822344 A ZA822344 A ZA 822344A ZA 822344 B ZA822344 B ZA 822344B
Authority
ZA
South Africa
Prior art keywords
drugs
piperazino
pyrimidine
intermediates
utilization
Prior art date
Application number
ZA822344A
Other languages
English (en)
Inventor
F Audiau
C Gueremy
Fur G Le
Original Assignee
Pharmindustrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmindustrie filed Critical Pharmindustrie
Publication of ZA822344B publication Critical patent/ZA822344B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA822344A 1981-04-07 1982-04-05 Derivatives of 2-piperazino pyrimidine, methods for their preparation and their utilization as drugs or intermediates for the manufacture of drugs ZA822344B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8106924A FR2503162A1 (fr) 1981-04-07 1981-04-07 Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments

Publications (1)

Publication Number Publication Date
ZA822344B true ZA822344B (en) 1983-02-23

Family

ID=9257094

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA822344A ZA822344B (en) 1981-04-07 1982-04-05 Derivatives of 2-piperazino pyrimidine, methods for their preparation and their utilization as drugs or intermediates for the manufacture of drugs

Country Status (21)

Country Link
US (1) US4535080A (xx)
EP (1) EP0063509B1 (xx)
JP (1) JPS57179167A (xx)
AR (1) AR231442A1 (xx)
AT (1) AT386199B (xx)
AU (1) AU549748B2 (xx)
CA (1) CA1175427A (xx)
DE (1) DE3262374D1 (xx)
DK (1) DK156722C (xx)
ES (4) ES8306745A1 (xx)
FI (1) FI78909C (xx)
FR (1) FR2503162A1 (xx)
GR (1) GR77331B (xx)
HU (1) HU187673B (xx)
IE (1) IE52872B1 (xx)
IL (1) IL65422A (xx)
MA (1) MA19438A1 (xx)
MX (1) MX156087A (xx)
NO (1) NO158739C (xx)
PT (1) PT74712B (xx)
ZA (1) ZA822344B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3305524A1 (de) * 1983-02-18 1984-08-23 Celamerck Gmbh & Co Kg, 6507 Ingelheim Neue pyrimidinderivate
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
JPS6143173A (ja) * 1984-08-06 1986-03-01 Mitsui Petrochem Ind Ltd 新規ピリミジン誘導体およびその製法
WO1987004928A1 (en) * 1986-02-24 1987-08-27 Mitsui Petrochemical Industries, Ltd. Agents for treating neurophathy
JP2561689B2 (ja) * 1986-02-24 1996-12-11 三井石油化学工業株式会社 神経疾患用治療薬
WO1989000423A1 (en) 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
CN101437843B (zh) * 2006-01-23 2013-08-07 密歇根州立大学评议会 抗草甘膦植物的育种方法及组合物
WO2010022121A1 (en) * 2008-08-20 2010-02-25 Schering Corporation Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
PE20120325A1 (es) * 2009-05-19 2012-04-12 Dow Agrosciences Llc Aminopirimidinas sustituidas con arilo como agentes fungicidas
CN103204816B (zh) * 2012-01-16 2016-04-27 中国人民解放军军事医学科学院毒物药物研究所 哌嗪基嘧啶类衍生物及其制备方法和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE485737A (xx) * 1947-11-12
FR2257294B1 (xx) * 1973-07-06 1977-07-01 Ugine Kuhlmann
NL129219C (xx) * 1965-12-16
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
FR2173746B1 (xx) * 1972-03-01 1975-04-25 Ugine Kuhlmann
FR2244520B1 (xx) * 1973-07-06 1977-02-04 Ugine Kuhlmann
JPS578104B2 (xx) * 1973-09-20 1982-02-15
GB1523274A (en) * 1974-08-05 1978-08-31 Ici Ltd Herbicidal compositions containing substituted pyrimidine
US4166852A (en) * 1974-08-09 1979-09-04 Produits Chimiques Ugine Kuhlmann Piperazino-pyrimidines and their use as spasmolytic agents
FR2281117A2 (fr) * 1974-08-09 1976-03-05 Ugine Kuhlmann Nouvelles piperazino-pyrimidines utilisables comme medicaments
FR2311776A1 (fr) * 1975-05-23 1976-12-17 Sogeras Diamino-2,4 bromo-5 chloro-6 pyrimidines et procede pour leur preparation
FR2417507A2 (fr) * 1977-07-28 1979-09-14 Ugine Kuhlmann Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides

Also Published As

Publication number Publication date
CA1175427A (fr) 1984-10-02
FI821203L (fi) 1982-10-08
ES511224A0 (es) 1983-06-01
PT74712B (fr) 1983-10-25
IE820774L (en) 1982-10-07
NO821159L (no) 1982-10-08
JPS57179167A (en) 1982-11-04
FR2503162A1 (fr) 1982-10-08
ES8400427A1 (es) 1983-10-16
FI78909C (fi) 1989-10-10
NO158739C (no) 1988-10-26
ES8306745A1 (es) 1983-06-01
IL65422A (en) 1985-04-30
AT386199B (de) 1988-07-11
ES8400429A1 (es) 1983-10-16
FR2503162B1 (xx) 1983-11-25
FI78909B (fi) 1989-06-30
EP0063509A1 (fr) 1982-10-27
EP0063509B1 (fr) 1985-02-20
DK156722B (da) 1989-09-25
AR231442A1 (es) 1984-11-30
ES518974A0 (es) 1983-10-16
US4535080A (en) 1985-08-13
GR77331B (xx) 1984-09-11
DE3262374D1 (en) 1985-03-28
FI821203A0 (fi) 1982-04-06
ATA127682A (de) 1987-12-15
MX156087A (es) 1988-07-04
DK154382A (da) 1982-10-08
DK156722C (da) 1990-02-19
HU187673B (en) 1986-02-28
ES8400428A1 (es) 1983-10-16
NO158739B (no) 1988-07-18
MA19438A1 (fr) 1982-12-31
ES518976A0 (es) 1983-10-16
IE52872B1 (en) 1988-03-30
AU8245082A (en) 1982-10-14
ES518975A0 (es) 1983-10-16
AU549748B2 (en) 1986-02-13
PT74712A (fr) 1982-05-01
IL65422A0 (en) 1982-07-30

Similar Documents

Publication Publication Date Title
NO874764L (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
EP0169712A3 (en) New pyrimidine derivatives, processes for preparation thereof and composition containing the same
ZA822344B (en) Derivatives of 2-piperazino pyrimidine, methods for their preparation and their utilization as drugs or intermediates for the manufacture of drugs
EP0177287A3 (en) Pyrimidine derivatives, processes for preparation thereof and composition of the same
DE3264523D1 (en) Derivatives of 4-aminoethoxy-5-isopropyl-2-methyl phenol, process for their preparation and their use as medicines
IL86649A0 (en) 2-guanidino-thiazole derivatives,their preparation and use as intermediates
NO851920L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
DE3260932D1 (en) Process for the preparation of derivatives of resorcin, and the use of certain derivatives of resorcin as perfumes
EP0043054A3 (en) Pyrimidine derivatives, their preparation and use, medicaments containing them and intermediates for their preparation
ZW17085A1 (en) Process for the preparation of 8-halo-5,6-dialkoxyquinazoline-2,4-diones and their salts
NO863343D0 (no) Fremgangsmaate for fremstilling av gem-dihalo-1,8-diamido-4-aza-octaner.
DE3069781D1 (en) 2-amino-benzoic-acid derivatives, their preparation and their use as medicines or intermediates
IL76243A (en) Process and intermediates for the preparation of aromatic-1,4-oxazepinones and-thiones
DE3562012D1 (en) Pyrimidinediones and dihydroxypyrimidines, and process for the preparation of pyrimidinedones and dihydroxypyrimidines
IL65490A (en) 5-substituted 4-oxo-pgi2 derivatives,bicyclic compounds of similar structure,and process for the preparation thereof
EP0195743A3 (en) Enol ethers, process for their preparation, alpha-pyrones, process for their preparation and use of the alpha-pyrones
GB2107309B (en) Preparation of 2-amino-4-hydroxy-5-halo-substituted pyrimidine derivatives
IL65384A0 (en) Aminosulfenyl chloride derivatives,their preparation and their use as intermediates for preparing carbamate derivatives
DE3660597D1 (en) Process for the preparation of 5-fluorotoluene-2,4-disulfochloride
EP0161548A3 (en) Process for the preparation of riboflavin, and intermediates for this process
EP0267537A3 (en) Process for the preparation of vinylglyoxal derivatives, vinylglyoxal derivatives and their use
EP0195738A3 (en) Process for the preparation of n,n -diisopropyl-2-benzothiazyl-sulfenamide
IL80857A0 (en) Process for the preparation of 2-substituted 5-nitroso-4,6-diaminopyrimidines
NO851319L (no) Fremgangsmaate for fremstilling av eburnanderivater.
AU8825782A (en) Process for the preparation of urea